Detraining in People Living With HIV/AIDS

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

2 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-02-19

Study Completion Date

2016-07-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study was to evaluate the effect of detraining in the components of physical aptitude of people living with HIV/Aids (PVHA).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of Home-Based Resistance and Strength Training in HIV-Infected Women

NCT00111332

HIV Infections

COMPLETED NA

Exercise for Patients With HIV Infections

NCT00910936

HIV Infections Lipodystrophy Inflammation

UNKNOWN PHASE2/PHASE3

Cardiovascular Responses to Exercise in People Living With HIV/AIDS: Effects of Exercise Training

NCT04512456

HIV Infections

RECRUITING NA

Relationship Between Neuromuscular Fatigue, Perceived Tiredness and Level Of Physical Activity of Patients Living With HIV

NCT03124914

HIV Seropositivity

COMPLETED NA

Role of the Autonomic Nervous System in HIV-Lipodystrophy

NCT00149097

HIV Infections Lipodystrophy-Syndrome

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study was experimental with a sample composed by an Experimental Group (EG) with 11 PVHA, under antiretroviral therapy and a Control Group (CG) with 10 individuals without the infection; all which were under medical release and insufficiently active. The body composition was evaluated through the DXA, as well as the cardiorespiratory aptitude through the ergometer and the strength of the upper and lower limbs through dynamometry. Both groups conducted interventions with concurrent training for 15 weeks and the interruption of exercise was evaluated after a period of 5 weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lipodystrophy Syndrome, HIV Sarcopenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Intervention Model

SEQUENTIAL

This is a longitudinal study of the non-randomized experimental type, presenting a non-probabilistic sample for convenience and independent groups. The sample consisted of 21 individuals divided into 2 groups: Experimental Group (EG) and Control Group (CG). The EG was composed of 11 people living with HIV/AIDS and CG composed of 10 people with no infection

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

protocol with physical exercise

Both groups underwent a combined training intervention consisting of aerobic and resisted exercises in the same training session

Group Type EXPERIMENTAL

combined training

Intervention Type OTHER

Combined training consisting of aerobic and resisted training in the same training session for 15 weeks followed by 5 weeks of detraining

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

combined training

Combined training consisting of aerobic and resisted training in the same training session for 15 weeks followed by 5 weeks of detraining

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Group experience to have a diagnosis of at least 2 years living with HIV / AIDS being in clinical follow-up in the Specialized Attention Services in HIV / AIDS (SAE), using ART, TCD4 lymphocyte count equal to or greater than 500 copies / mm³, viral load Undetectable (≤ 50 copies / mm³)
* Group control without any diagnosis of HIV / AIDS or any other pathology. Both groups completed the exercise program with a minimum frequency of 75%.